This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Craniosynostosis두개골유합

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: Q75.0 | Special Copayment Reduction: V265 | Re-certification cycle: 5 years
B. SynonymsAcrocephaly, imperfect fusion of skull, Oxycephaly, trigonocephaly
C. Adult onsetLikelihood of first presentation in adulthood very low — craniosynostosis is a congenital premature fusion of the cranial sutures and is diagnosed in the neonatal and infant period. Some mild single-suture cases (involving one suture) are found in late infancy, but new presentation in adulthood is almost nonexistent.
1. HistoryVirchow's law formulated in 1851. Classification system established in the early 20th century. Advances in craniofacial surgery from the 1960s onward (Tessier). Molecular era opened in the 2000s with identification of genetic causes (FGFR, TWIST1, etc.).
2. CausesHereditary (single-gene variants, chromosomal abnormalities) and nonhereditary (environmental: intrauterine compression, maternal thyroid disease, smoking). Single-suture nonsyndromic about 85%, syndromic about 15%. Major genes include FGFR2, FGFR3, TWIST1 and EFNB1.
3. GeneticsSyndromic: FGFR2 (Apert, Crouzon, Pfeiffer), FGFR3 (Muenke), TWIST1 (Saethre-Chotzen), EFNB1 (Craniofrontonasal). Nonsyndromic: SMAD6, BMP2, TCF12, etc. Mostly autosomal dominant. High proportion of sporadic de novo mutations.
4. General epidemiologyAbout 1 in 2,500 births overall. Sagittal suture most common (~50%), unilateral coronal (~20%), metopic (~15%), lambdoid (~5%). Syndromic about 15%. More common in boys (nonsyndromic sagittal suture fusion: M:F≈3:1).
5. PathophysiologyAbnormal premature differentiation and proliferation of suture boundary stem cells (osteoprogenitors). FGF-FGFR signaling hyperactivation promotes ossification of suture mesenchymal cells. Restriction of normal cranial growth direction → compensatory growth (Virchow's law). Pathway to raised intracranial pressure.
6. SymptomsAbnormal skull shape (deformity specific to the main suture involved), raised intracranial pressure (headache, vomiting, visual disturbance), sleep apnea, proptosis, orbital asymmetry. Severe: optic nerve damage and delayed cognitive development when raised intracranial pressure becomes chronic.
7. SignsPalpable suture ridge, abnormal cephalic index (abnormal CI), early closure of the anterior fontanelle, orbitocranial shape asymmetry. Fundus: papilledema. Skull X-ray/CT: suture loss, digital markings (copper beaten appearance).
8. ScreeningNeonatal head circumference measurement and cephalic index measurement. Prenatal ultrasound (third trimester). Routine infant physical examination. Immediate CT referral if head circumference deviates from the growth curve.
9. DiagnosisSkull CT (3D reconstruction) is standard. Molecular genetic testing (panel including FGFR1/2/3, TWIST1, etc., or WES). Ophthalmologic and neurologic evaluation. Intracranial pressure monitoring (if needed).
10. TreatmentEarly surgery (3–12 months of age): endoscopic suturectomy, cranial vault remodeling (CVR). Severe and syndromic: fronto-orbital advancement (FOA), Monobloc and LeFort III osteotomy. Orthosis (helmet). Multidisciplinary approach.
11. PrognosisSingle-suture nonsyndromic: good prognosis for skull shape and development after early surgery. Syndromic and multisutural: repeated surgery, intracranial pressure management and long-term follow-up needed. Preventing optic nerve damage is important.
12. PreventionPrenatal diagnosis and genetic counseling for families with genetic causes. Management of maternal thyroid disease and smoking. Regular evaluation of neonatal head shape. Positional correction (prevention of positional plagiocephaly).
13. ReferencesMathijssen IMJ. Guideline for care of patients with craniosynostosis. J Craniofac Surg. 2015 and 9 other references

1. History

The scientific history of craniosynostosis begins with the pioneering study published in 1851 by the German pathologist Rudolf Virchow. Virchow formulated Virchow's law, which states that cranial growth is restricted perpendicular to a fused cranial suture and compensatory growth occurs parallel to it. This law became the basis for predicting the pattern of skull deformity for each type of suture fusion and is still used today as the foundation of craniosynostosis classification. Even before Virchow, the Arab physician Al-Zahrawi (10th century) described abnormal skull shapes, and there were sporadic case reports in Europe, but systematic understanding originated with Virchow.

In the first half of the 20th century, a clinical classification of craniosynostosis based on skull shape was established. A morphologic classification system was developed, including scaphocephaly/dolichocephaly (sagittal suture fusion), trigonocephaly (metopic suture fusion), brachycephaly (bilateral coronal suture fusion), plagiocephaly (unilateral coronal or unilateral lambdoid suture fusion) and turricephaly/oxycephaly (multisutural fusion). This classification is still widely used in clinical practice.

The revolutionary turning point in the surgical treatment of craniosynostosis came in 1967, when Paul Tessier of France established the system of craniofacial surgery. Tessier integrated the entire cranial and facial skeleton into the surgical field and developed frontal orbital advancement, monobloc osteotomy and other procedures. This made functional and aesthetic correction of severe syndromic craniosynostosis possible. In the 1990s, minimally invasive endoscopic suturectomy was introduced, greatly reducing transfusion requirements and complication rates for early surgery (at 3–6 months of age).

The molecular genetic era began in 1994–1995, when variants in the FGFR2 (Fibroblast Growth Factor Receptor 2) gene were found to cause Crouzon syndrome and Apert syndrome. Subsequently, FGFR1 (Pfeiffer syndrome), FGFR3 (Muenke syndrome), TWIST1 (Saethre-Chotzen syndrome) and EFNB1 (craniofrontonasal syndrome) were reported in succession. Since the 2000s, whole-exome sequencing (WES) has continued to identify new causative genes for nonsyndromic craniosynostosis (SMAD6, BMP2, TCF12, ERF, etc.), and more than 50 causative genes are now known. These molecular genetic advances have greatly raised the level of precision diagnosis and genetic counseling and are laying the foundation for future development of targeted therapies.

In Korea, as pediatric neurosurgery and craniofacial surgery developed after the 1980s, surgical treatment of craniosynostosis began to be performed at major medical institutions. Currently, Asan Medical Center, Seoul National University Hospital, Samsung Medical Center, Yonsei University Severance Hospital and others operate multidisciplinary craniosynostosis clinics, and a national patient registry and research are under way.

2. Causes

The causes of craniosynostosis are broadly divided into hereditary and nonhereditary (environmental); about 15–20% of all cases are syndromic and the remaining about 80–85% are non-syndromic. Syndromic craniosynostosis is mostly caused by specific gene variants and is accompanied by abnormalities of the limbs, face and internal organs in addition to the skull. Nonsyndromic craniosynostosis involves only premature fusion of a single suture, and some cases result from the interaction of environmental factors and polygenic predisposition.

Major genetic causes: FGFR2 gene variants cause Crouzon syndrome (p.C342R/Y, etc.), Apert syndrome (p.S252W, p.P253R), Pfeiffer syndrome types 2 and 3, and Jackson-Weiss syndrome. FGFR1 (p.P252R) variants are found in Pfeiffer syndrome type 1. FGFR3 (p.P250R) variants cause Muenke syndrome and are the most common hereditary cause of unilateral or bilateral coronal suture fusion. The TWIST1 gene (simple single-nucleotide variants or deletions) causes Saethre-Chotzen syndrome, which is characterized by incomplete penetrance. EFNB1 (ephrin B1) gene variants cause X-linked craniofrontonasal syndrome, characterized by a paradoxical sex bias in which females show a more severe phenotype.

Genetic causes of nonsyndromic craniosynostosis: traditionally considered to have environmental and polygenic mechanisms, but recent studies are identifying numerous single-gene causes, including SMAD6 (a BMP signaling inhibitor, associated with sagittal suture fusion), BMP2, TCF12, ERF, CDC45 and CSNK2A1. SMAD6 variants in particular cause nonsyndromic sagittal suture fusion through accelerated suture ossification due to upregulated BMP signaling.

Environmental causes: physical intrauterine compression (uterine malformation, twins, fixed fetal head position) may affect fetal cranial molding. In epidemiological studies, maternal smoking, use of antiepileptic drugs such as valproate, use of retinoids and thyroid disease (in hyperthyroidism, T3 is known to promote cranial suture ossification) are associated with the risk of craniosynostosis. The incidence of craniosynostosis has also been reported to be somewhat increased in pregnancies after assisted reproductive technology. Advanced paternal age is known to increase the frequency of FGFR2 and FGFR3 de novo mutations, which is explained by the 'selfish spermatogonial selection' phenomenon, in which cells with FGF receptor variants selectively proliferate among sperm cells.

3. Genetics

The genetics of craniosynostosis should be understood by dividing it into syndromic and nonsyndromic forms, which differ in mode of inheritance, associated genes and phenotypic spectrum. Most syndromic craniosynostoses follow autosomal dominant (AD) inheritance, and a substantial proportion result from de novo mutations.

FGFR gene family: the FGF receptors (FGFR1, FGFR2, FGFR3) are tyrosine kinase receptors that play a key role in bone formation and cranial suture development. Among FGFR2 variants, those of Apert syndrome (p.S252W or p.P253R) are almost all de novo mutations and are strongly associated with advanced paternal age. Crouzon syndrome also mostly arises from de novo mutations or autosomal dominant inheritance, and cysteine residue substitution variants within immunoglobulin-like domain III (IgIII) of FGFR2 (e.g., p.C342R, p.C342W, p.Y340C) account for over 80%. Pfeiffer syndrome (FGFR1 p.P252R or various FGFR2 variants) has a broad phenotype ranging from mild type 1 to lethal type 3. Muenke syndrome (FGFR3 p.P250R) is characterized by a variable phenotype and incomplete penetrance and is sometimes misdiagnosed as nonsyndromic coronal suture fusion, so genetic testing is essential.

TWIST1 gene: TWIST1 is a basic helix-loop-helix (bHLH) transcription factor that regulates mesenchymal cell differentiation. In Saethre-Chotzen syndrome, TWIST1 haploinsufficiency causes premature cranial suture fusion, ptosis and syndactyly. 7p21 deletions of the TWIST1 gene also cause a clinically identical syndrome. Because incomplete penetrance and variable phenotypic expression are characteristic, genetic analysis is recommended even for mild phenotypes within the family.

Genes in nonsyndromic craniosynostosis: SMAD6 (17q21.2) variants account for about 2–5% of nonsyndromic sagittal suture fusion, and because penetrance is low, the mutation is sometimes transmitted even without a family history. TCF12 (coronal suture fusion), ERF (multisutural fusion, orbitocranial abnormalities), CDC45 (associated with Meier-Gorlin syndrome) and others are also reported in nonsyndromic forms. Whole-exome sequencing identifies pathogenic variants in about 10–20% of patients with nonsyndromic craniosynostosis. Genetic testing has great clinical value in determining whether the condition is syndromic, estimating recurrence risk and evaluating other accompanying malformations.

4. General epidemiology

Craniosynostosis is relatively common among congenital cranial malformations and is reported to occur worldwide in about 1 in 2,000–2,500 births. Estimates vary somewhat by country and research method, but in meta-analyses the overall birth frequency converges at around 1/2,500. No significant difference in incidence between Western countries and East Asia has been reported, but there may be ethnic differences in the proportion of syndromic cases or the frequency of involvement of particular sutures.

Frequency of involvement by suture: the most commonly fused suture is the sagittal suture, accounting for about 40–55% of the total and causing the characteristic scaphocephaly deformity. Premature sagittal suture fusion is more than 3 times more common in boys than in girls. The second most common is the coronal suture, accounting for about 20–25% of the total; unilateral fusion (plagiocephaly) is more common in girls. Metopic suture fusion accounts for about 15–20% of the total and causes trigonocephaly. Lambdoid suture fusion is the rarest at about 3–5%, and differentiation from positional plagiocephaly is important. Multisutural fusion accounts for about 5–15% and is closely associated with syndromic forms.

Syndromic versus nonsyndromic: about 80–85% of all craniosynostosis is nonsyndromic and 15–20% is syndromic. Most nonsyndromic single-suture fusion is sporadic, but familial occurrence is reported in about 5–10%. Muenke syndrome (FGFR3 p.P250R) is the most common single-gene cause among syndromic forms, accounting for about 2–3% of all craniosynostosis. Crouzon syndrome occurs in about 1 in 50,000, Apert syndrome in about 1 in 60,000–160,000 and Pfeiffer syndrome in about 1 in 100,000.

Epidemiology in Korea: systematic epidemiological data in Korea are limited, but analyses of National Health Insurance Service data report a similar incidence. Craniosynostosis is registered as a rare disease designated for Special Copayment Reduction (V265) under National Health Insurance, and an estimated several hundred new patients receive Special Copayment Reduction registration each year. Because diagnosis is made after birth, active evaluation is needed when abnormal head shape is found in neonatal and infant outpatient clinics.

5. Pathophysiology

The pathophysiology of craniosynostosis is understood as an abnormality of the molecular pathways involved in the normal development and maintenance of cranial sutures. Normally, cranial sutures are fibrous mesenchymal tissue located between the cranial bones and function as growth plates for cranial growth during infancy. Virchow's law states that when a suture ossifies prematurely, growth in that direction is restricted and compensatory growth occurs in the direction of open sutures.

FGF-FGFR signaling pathway: the best-characterized molecular mechanism in cranial suture development is the fibroblast growth factor (FGF)–receptor (FGFR) signaling pathway. At normal suture boundaries, FGF signaling is maintained at a moderate level, balancing the proliferation and differentiation of osteoblast precursor cells. FGFR2 gain-of-function variants keep the receptor continuously active independently of FGF ligand, promoting premature osteoblast differentiation of suture mesenchymal cells and resulting in premature ossification of the suture. FGFR activation regulates the proliferation, differentiation and death of suture cells in a complex manner through downstream pathways such as RAS-ERK, PI3K-AKT and PLC-γ.

BMP signaling pathway: Bone Morphogenetic Protein (BMP) signaling acts to promote suture ossification. Normally, BMP inhibitors such as SMAD6 suppress excessive BMP signaling and maintain suture patency. With SMAD6 loss-of-function variants, BMP signaling becomes excessively activated and premature suture ossification occurs. In experimental studies, BMP2-overexpressing mouse models show premature cranial suture fusion.

TWIST1 transcription factor: the TWIST1 protein is essential for maintaining the undifferentiated state of suture mesenchymal stem cells. With TWIST1 haploinsufficiency, suture mesenchymal cells differentiate prematurely into osteoblasts and the suture closes early. TWIST1 interacts reciprocally with FGFR signaling to maintain suture patency. Recent studies have shown that TWIST1 also regulates angiogenesis through VEGF signaling, maintaining the oxygen and nutrient supply of suture mesenchymal cells.

Mechanism of raised intracranial pressure: when cranial volume is restricted relative to the rate of brain growth, intracranial pressure rises. Raised intracranial pressure is reported in about 15–20% of single-suture nonsyndromic craniosynostosis and in more than 50% of syndromic and multisutural fusion. Raised intracranial pressure causes papilledema, optic atrophy, hearing loss and delayed cognitive development. In particular, airway narrowing (upper airway narrowing, sleep apnea) accompanying syndromic craniosynostosis aggravates raised intracranial pressure.

6. Symptoms

The clinical symptoms of craniosynostosis vary with the type and number of fused sutures, the presence of raised intracranial pressure and whether the condition is syndromic. They can be broadly divided into abnormal skull shape, symptoms related to raised intracranial pressure, orbital and facial abnormalities, and accompanying extracranial symptoms.

Abnormal skull shape (deformity specific to each suture): premature sagittal suture fusion restricts growth so that the head does not widen from side to side but lengthens front to back, causing scaphocephaly/dolichocephaly. The cephalic index (CI = maximum head width/maximum head length × 100) decreases to 75 or less. Premature unilateral coronal suture fusion causes anterior plagiocephaly, characterized by flattening and asymmetry of the forehead and orbit, with the characteristic 'harlequin eye deformity' in which the supraorbital rim on the affected side moves posterosuperiorly. Bilateral coronal suture fusion causes brachycephaly, characterized by frontal flattening and an increased head index (CI > 85). Metopic suture fusion causes trigonocephaly, characterized by a midline forehead ridge, a triangular frontal shape and narrowed interorbital distance (hypotelorism). In multisutural fusion, turricephaly/oxycephaly forms, with the head growing vertically.

Symptoms of raised intracranial pressure: with moderate or greater raised intracranial pressure, headache (especially a pattern of worsening on waking in the morning), nausea and vomiting, and irritability are the main symptoms in infants. With further progression, reduced vision and visual field defects due to papilledema, nystagmus, abducens nerve palsy (sixth nerve palsy) and delayed cognitive and language development appear. In infants, raised intracranial pressure may present with nonspecific symptoms such as loud crying, sleep disturbance and feeding refusal.

Sleep apnea and airway problems: in syndromic craniosynostosis, especially Crouzon, Apert and Pfeiffer syndromes with midface hypoplasia, obstructive sleep apnea (OSA) due to upper airway narrowing is common. In severe cases, tracheostomy is needed. Sleep apnea causes chronic CO₂ retention and worsens raised intracranial pressure, so early evaluation and management are important. Ocular and visual symptoms: in syndromic craniosynostosis, proptosis due to reduced orbital volume, exposure keratopathy, strabismus and refractive errors are common. If papilledema is found on fundoscopy, immediate management of intracranial pressure is needed.

7. Signs

The physical signs of craniosynostosis are confirmed by a systematic examination including assessment of skull shape, suture palpation, ophthalmologic examination and neurologic evaluation.

Skull shape and suture palpation findings: a ridge or groove is palpable at the prematurely fused suture. In sagittal suture fusion, a bony ridge is felt along the parietal midline, and in metopic suture fusion, a bony ridge is found in the middle of the forehead. If the anterior fontanelle closes earlier than normal (normal closure: 12–18 months) or is bulging on palpation, raised intracranial pressure is suggested. Caution is needed when the rate of head circumference growth deviates from its growth percentile, especially when head circumference falls below its growth curve.

Cephalic index and cranial measurements: a cephalic index (CI = maximum head width/maximum head length × 100) of 76 or less (scaphocephaly) or 86 or more (brachycephaly) is used, and in metopic suture fusion, trigonocephaly is quantified by a decreased metopic angle. In plagiocephaly, asymmetry of cranial diagonal lengths is used for plagiocephaly index measurement (plagiocephalometry). Ophthalmologic signs: papilledema is the most important objective sign of raised intracranial pressure and appears on fundoscopy as blurred optic disc margins, disc hyperemia, loss of venous pulsation and retinal venous dilation. Proptosis is quantified with a Hertel exophthalmometer; values over 18mm or asymmetry between the eyes of 2mm or more are clinically significant.

Neurologic signs: with chronically raised intracranial pressure, esotropia due to abducens nerve (sixth cranial nerve) palsy appears, and in advanced cases, reduced vision, color vision abnormalities and visual field defects. Developmental assessment may reveal delayed language development and cognitive decline. Imaging signs: on skull X-ray, in older children, digital markings (copper beaten appearance) suggest raised intracranial pressure. 3D reconstruction of skull CT confirms suture loss, suture sclerosis and abnormal skull shape.

8. Screening

There is no population-wide newborn screening program for craniosynostosis, but systematic assessment of skull shape during neonatal and infant health checkups functions as the practical screening tool.

Neonatal and infant physical examination: abnormal head shape should be checked from immediately after birth. Head circumference is recorded on a growth percentile chart, and the cephalic index (CI) is measured or head shape is assessed visually. If the head is excessively narrow (CI < 76), the forehead is triangular, or forehead and orbital asymmetry is clear, imaging is requested. If palpation of the sutures reveals an abnormal ridge or early loss of a suture, immediate skull CT evaluation is needed.

Prenatal ultrasound screening: if routine second-trimester (18–22 weeks) ultrasound shows abnormal skull shape (abnormal BPD/OFD ratio, triangular forehead, flattened skull shape), additional third-trimester ultrasound or fetal MRI is performed, and chromosomal and genetic testing is considered. Severe syndromic craniosynostosis (especially Apert syndrome) is sometimes suspected on prenatal ultrasound from characteristic cranial and limb findings.

Screening of high-risk groups with a family history: in families with a confirmed genetic cause such as FGFR2, FGFR3 or TWIST1 variants, genetic analysis during pregnancy (CVS or amniocentesis) determines whether the fetus is affected. Because mild phenotypes (Muenke syndrome, Saethre-Chotzen syndrome) may be transmitted undiagnosed within a family, screening genetic testing of family members is recommended. Deviation in head circumference growth: at infant health checkups (at 1, 2, 4, 6, 9 and 12 months of age), deviation from the head circumference growth percentile or a sharp decline suggests craniosynostosis or a problem of cranial growth and is used as a criterion for imaging referral.

9. Diagnosis

Diagnosis of craniosynostosis is based on clinical evaluation and imaging, with molecular genetic testing added to identify the cause.

Skull CT with 3D reconstruction: the standard imaging test for diagnosing craniosynostosis. Thin-slice skull CT confirms suture loss (the suture ossified continuously with the adjacent cranial bones), suture sclerosis and thickening of the cranial bone around the suture. 3D reconstruction images are essential for three-dimensional evaluation of the extent of fused sutures, the degree of skull deformity, orbital volume and skull base structure, and are also used for surgical planning. To minimize radiation exposure, a low-dose skull CT protocol is used, and subsequent follow-up scans are performed selectively according to clinical need.

Brain MRI: used to evaluate ventricular enlargement (hydrocephalus), cerebellar tonsillar descent (Chiari malformation, which may accompany Pfeiffer and Crouzon syndromes in particular), abnormalities of brain development and optic atrophy. When syndromic craniosynostosis is diagnosed, evaluation for accompanying brain malformations by brain MRI is recommended. It is superior to CT for soft tissue evaluation without radiation, but CT takes priority for suture evaluation.

Ophthalmologic examination: includes fundoscopy (assessment of papilledema), visual acuity and refraction testing, strabismus evaluation and proptosis measurement. If raised intracranial pressure is suspected or there are findings of reduced orbital volume, optical coherence tomography (OCT) quantifies optic nerve thickness. Molecular genetic testing: when syndromic craniosynostosis is suspected, a craniosynostosis gene panel including FGFR1, FGFR2, FGFR3, TWIST1 and others is performed. If the panel is negative, whole-exome sequencing (WES) or whole-genome sequencing (WGS) is considered. Even in nonsyndromic cases, genetic testing is performed if there is a family history or recurrence risk needs to be estimated. Intracranial pressure monitoring: when raised intracranial pressure is clinically suspected or papilledema is present, intracranial pressure measurement (insertion of an epidural or subdural sensor) is used for treatment decisions. As noninvasive methods, ophthalmologic optic nerve OCT, auditory brainstem response (ABR) and assessment of digital markings on skull X-ray are used as adjuncts.

10. Treatment

Treatment of craniosynostosis aims at correcting skull shape, preventing and treating raised intracranial pressure, correcting orbital and facial deformities, securing the airway and supporting development, and an integrated approach by a multidisciplinary team including pediatric neurosurgery, craniofacial surgery, ophthalmology, otolaryngology, pediatrics and genetics is essential.

Endoscopic suturectomy: a minimally invasive procedure applied in early surgery at 3–6 months of age, in which the fused suture is resected endoscopically to allow cranial growth. It is used mainly for single sagittal or metopic suture fusion, and a cranial remolding orthosis is worn for 3–6 months after surgery to guide growth into the desired head shape. Compared with open cranial surgery, it has the advantages of lower transfusion requirements, faster recovery and shorter hospital stay.

Cranial vault remodeling (CVR): open cranial surgery performed at 6–12 months of age, in which the fused suture and surrounding cranial bone are removed and reshaped and fixed to fit a normal head shape. Frontal Orbital Advancement (FOA) advances the frontal region and supraorbital rim in coronal suture fusion to correct forehead shape and orbital volume. In sagittal suture fusion, posterior vault remodeling or combined anterior–posterior cranial vault remodeling is performed. In trigonocephaly (metopic suture fusion), frontal reshaping is performed through a frontonasal approach.

Surgery for syndromic and multisutural fusion: in multisutural fusion with raised intracranial pressure, posterior cranial vault distraction to enlarge cranial volume or total cranial vault remodeling is performed. In midface retrusion (Crouzon, Apert), midface advancement is performed after growth (usually after age 6–10 years) by LeFort III osteotomy or monobloc osteotomy to improve eye protection and secure the airway. Gradual bone advancement is possible using distraction osteogenesis. If airway problems are severe (Pfeiffer syndrome types 2 and 3), tracheostomy may be needed. Helmet therapy: after endoscopic surgery or in mild cases, a cranial remolding helmet is worn from 6 to 18 months of age to correct head shape. It is applied after differentiation from positional plagiocephaly. Helmets are also used as an adjunct after cranial vault remodeling.

11. Prognosis

The prognosis of craniosynostosis varies greatly depending on the number and type of fused sutures, whether the condition is syndromic, the presence and duration of raised intracranial pressure, and the timing and outcome of surgery.

Nonsyndromic single-suture fusion: with early surgery (before 12 months of age), the prognosis for skull shape and neurodevelopment is generally good. In premature sagittal suture fusion, satisfactory head shape correction is achieved in about 85–90% of patients who undergo endoscopic suturectomy followed by helmet therapy. Intelligence and cognitive development in patients with single-suture fusion are mostly in the normal range, but learning disabilities, delayed language development and attention deficits are reported when there was uncorrected raised intracranial pressure. Early diagnosis and surgery are therefore the key determinants of neurodevelopmental outcome.

Syndromic craniosynostosis: the prognosis is more complex, requiring repeated surgery, long-term follow-up and multidisciplinary management. In Apert syndrome, moderate to severe intellectual disability is present in about 50–60%, but some have normal intelligence. Crouzon syndrome often has normal intelligence, but cognitive decline occurs if raised intracranial pressure is not adequately managed. Pfeiffer syndrome type 1 commonly has normal intelligence, but types 2 and 3 are accompanied by severe neurodevelopmental disorders. Regular ophthalmologic follow-up (papilledema, vision, proptosis) and neuropsychological evaluation are recommended for all syndromic patients.

Visual prognosis: optic atrophy due to chronically raised intracranial pressure causes irreversible vision loss. When papilledema is found, immediate intracranial pressure decompression surgery is decisive for preserving vision. Exposure keratopathy due to proptosis also requires early ophthalmologic treatment. Long-term follow-up: even after surgery, regular follow-up throughout the growth period (at least until age 16–18) is needed to monitor for suture refusion, re-elevation of intracranial pressure and abnormal midface development. Skull shape is reassessed with growth, and additional surgery is performed if needed.

12. Prevention

Complete primary prevention of craniosynostosis is impossible in syndromic forms, which are mostly genetic in cause, but genetic counseling and prenatal diagnosis play an important role in families at risk of recurrence. In nonsyndromic craniosynostosis, avoiding environmental risk factors may have some preventive value.

Genetic counseling and prenatal diagnosis: in families of patients with a confirmed genetic cause (variants in FGFR2, FGFR3, TWIST1, etc.), recurrence risk is estimated through genetic counseling, and genetic analysis by prenatal CVS or amniocentesis determines whether the fetus is affected. Preimplantation genetic testing (PGT) is also possible in autosomal dominant craniosynostosis. In new de novo cases, the recurrence risk is low, but because of the possibility of gonadal mosaicism, prenatal diagnosis is considered in subsequent pregnancies as well.

Management of environmental risk factors: avoid smoking during pregnancy, and review before pregnancy the need for drugs associated with craniosynostosis risk, such as valproate. If the mother has hyperthyroidism, thyroid function is kept within the normal range before and during pregnancy. When assisted reproduction is performed, the risk of multiple pregnancy is thoroughly discussed and single-embryo transfer is preferred. Prevention of positional plagiocephaly: positional plagiocephaly, which must be differentiated from nonsyndromic single-suture fusion, is prevented by following the principle of supine sleep for infants (SIDS prevention) together with sufficient prone time (tummy time) to prevent cranial deformity. If abnormal head shape is observed, imaging differentiates it from true craniosynostosis, and early intervention is undertaken. Early detection and treatment: because the prognosis of craniosynostosis improves markedly with early detection and treatment (before 12 months of age), systematically assessing head shape at neonatal and infant checkups and immediately referring abnormal findings to a specialist is the best secondary prevention.

13. References

  1. Mathijssen IMJ. Guideline for care of patients with the diagnoses of craniosynostosis: working group on craniosynostosis. J Craniofac Surg. 2015;26(6):1735-1807. DOI: 10.1097/SCS.0000000000002016. PMID: 26355968.

  2. Wilkie AOM, Byren JC, Hurst JA, et al. Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis. Pediatrics. 2010;126(2):e391-400. DOI: 10.1542/peds.2009-3491. PMID: 20643724.

  3. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet. 1994;8(1):98-103. DOI: 10.1038/ng0994-98. PMID: 7987400.

  4. Wilkie AO, Slaney SF, Oldridge M, et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet. 1995;9(2):165-172. DOI: 10.1038/ng0295-165. PMID: 7719344.

  5. Muenke M, Schell U, Hehr A, et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet. 1994;8(3):269-274. DOI: 10.1038/ng1194-269. PMID: 7874169.

  6. Howard TD, Paznekas WA, Green ED, et al. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet. 1997;15(1):36-41. DOI: 10.1038/ng0197-36. PMID: 8988166.

  7. Greenwald JA, Mehrara BJ, Spector JA, et al. In vivo modulation of FGF biological activity alters cranial suture fate. Am J Pathol. 2001;158(2):441-452. DOI: 10.1016/S0002-9440(10)63987-9. PMID: 11159183.

  8. Proctor MR, Meara JG. A review of the management of single-suture craniosynostosis, past, present, and future. J Neurosurg Pediatr. 2019;24(6):622-631. DOI: 10.3171/2019.8.PEDS19417. PMID: 31604323.

  9. Lattanzi W, Barba M, Di Pietro L, Bernardini C. Genetic bases of craniosynostosis: an update. Childs Nerv Syst. 2017;33(8):1307-1321. DOI: 10.1007/s00381-017-3422-0. PMID: 28593459.

  10. Renier D, Sainte-Rose C, Marchac D, Hirsch JF. Intracranial pressure in craniostenosis. J Neurosurg. 1982;57(3):370-377. DOI: 10.3171/jns.1982.57.3.0370. PMID: 7108375.